Synthesis and Pharmacological Activity of a Potent Inhibitor of the Biosynthesis of the Endocannabinoid 2-Arachidonoylglycerol

被引：35

作者：

Bisogno, Tiziana ^{[1
]}

Burston, James J. ^{[2
]}

Rai, Ravi ^{[3
]}

Allara, Marco ^{[1
]}

Saha, Bijali ^{[3
]}

Mahadevan, Anu ^{[3
]}

Razdan, Raj K. ^{[3
]}

Wiley, Jenny L. ^{[2
]}

Di Marzo, Vincenzo ^{[1
]}

机构：

[1] CNR, Inst Biomol Chem, Endocannabinoid Res Grp, Pozzuali, NA, Italy

[2] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA

[3] Organix Inc, Woburn, MA 01801 USA

来源：

CHEMMEDCHEM | 2009年 / 4卷 / 06期

基金：

美国国家卫生研究院;

关键词：

biosynthesis; CB1; DAGL; endocannabinoids; cannabinoids; receptors; FOOD-INTAKE; SYSTEM;

D O I：

10.1002/cmdc.200800442

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

(Chemical Equation Presented) Biosynthesis Inhibition: O-5596, a new inhibitor of the biosynthesis of the endocannabinoid, 2-arachidonoylglycerol, was synthesized and found to be potent (IC50=100 nm) and selective versus other proteins and enzymes of the endocannabinoid system in vitro and active in vivo at reducing food intake in mice. © 2009 Wiley-VCH Verlag GmbH & Co. KGaA.

引用

页码：946 / 950

页数：5

共 23 条

[1] Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain
Bisogno, T
Howell, F
Williams, G
Minassi, A
Cascio, MG
Ligresti, A
Matias, I
Schiano-Moriello, A
Paul, P
Williams, EJ
Gangadharan, U
Hobbs, C
Di Marzo, V
Doherty, P
[J]. JOURNAL OF CELL BIOLOGY, 2003, 163 (03) : 463 - 468
[2] Development of the first potent and specific inhibitors of endocannabinoid biosynthesis
Bisogno, T
Cascio, MG
Saha, B
Mahadevan, A
Urbani, P
Minassi, A
Appendino, G
Saturnino, C
Martin, B
Razdan, R
Di Marzo, V
[J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2006, 1761 (02): : 205 - 212
[3] Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity
Blueher, Matthias
Engeli, Stefan
Kloeting, Nora
Berndt, Janin
Fasshauer, Mathias
Batkai, Sandor
Pacher, Pal
Schoen, Michael R.
Jordan, Jens
Stumvoll, Michael
[J]. DIABETES, 2006, 55 (11) : 3053 - 3060
[4] A structure-activity relationship study on N-arachidonoyl-amino acids as possible endogenous inhibitors of fatty acid amide hydrolase
Cascio, MG
Minassi, A
Ligresti, A
Appendino, G
Burstein, S
Di Marzo, V
[J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 314 (01) : 192 - 196
[5] Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men
Cote, M.
Matias, I.
Lemieux, I.
Petrosino, S.
Almeras, N.
Despres, J-P
Di Marzo, V.
[J]. INTERNATIONAL JOURNAL OF OBESITY, 2007, 31 (04) : 692 - 699
[6] Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Cravatt, BF
Giang, DK
Mayfield, SP
Boger, DL
Lerner, RA
Gilula, NB
[J]. NATURE, 1996, 384 (6604) : 83 - 87
[7] Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors
Di Marzo, V.
Cote, M.
Matias, I.
Lemieux, I.
Arsenault, B. J.
Cartier, A.
Piscitelli, F.
Petrosino, S.
Almeras, N.
Despres, J. -P.
[J]. DIABETOLOGIA, 2009, 52 (02) : 213 - 217
[8] Leptin-regulated endocannabinoids are involved in maintaining food intake
Di Marzo, V
Goparaju, SK
Wang, L
Liu, J
Bátkai, S
Járai, Z
Fezza, F
Miura, GI
Palmiter, RD
Sugiura, T
Kunos, G
[J]. NATURE, 2001, 410 (6830) : 822 - 825
[9] Endocannabinoid control of food intake and energy balance
Di Marzo, V
Matias, I
[J]. NATURE NEUROSCIENCE, 2005, 8 (05) : 585 - 589
[10] Play an ADAGIO with a STRADIVARIUS: the right patient for CB1 receptor antagonists?
Di Marzo, Vincenzo
[J]. NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2008, 5 (10): : 610 - 612

← 1 2 3 →